Chromosome 4 is one of the larger human chromosomes, carrying roughly 190 million base pairs and an estimated 700 to 1,000 protein-coding genes. It plays roles in an unusually wide range of biological functions, from brain health and bone growth to blood clotting, alcohol metabolism, and immune signaling. Several high-profile genetic conditions trace directly to this chromosome, including Huntington’s disease and a common form of dwarfism, but the full catalog of genes it harbors touches nearly every organ system in the body.
Huntington’s Disease and the HTT Gene
The gene most famously associated with chromosome 4 is HTT, which encodes the huntingtin protein. Huntington’s disease arises when a short stretch of DNA inside this gene, a repeating sequence of the nucleotides C-A-G, expands beyond a critical length. In most people, the HTT gene contains fewer than 36 CAG repeats. When the count climbs above that threshold, the resulting protein misfolds and gradually damages neurons, particularly in brain regions that control movement and cognition. Symptoms typically emerge in middle age and include involuntary movements, personality changes, and progressive cognitive decline.
The relationship between repeat length and disease is not perfectly clean-cut. People carrying what researchers call “intermediate” repeat counts, in the mid-30s range, sometimes develop symptoms that look like Huntington’s but do not always fit the classic diagnosis. A study of an Israeli Karaite community found cases suggesting the disease could appear with as few as 34 CAG repeats, likely influenced by additional genes that have not yet been identified.1PubMed. Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene The repeat count also tends to grow across generations, especially when inherited from the father. Research in Finnish families showed that paternal transmission added an average of about 1.4 CAG units per generation, with certain genetic backgrounds on chromosome 4 seeing even larger jumps.2PubMed Central. HTT haplogroups in Finnish patients with Huntington disease This instability is one reason Huntington’s can appear earlier and more severely in successive generations of the same family.
Parkinson’s Disease and Alpha-Synuclein
Chromosome 4 also hosts SNCA, the gene encoding a protein called alpha-synuclein. This protein accumulates in abnormal clumps called Lewy bodies inside the brains of people with Parkinson’s disease, making it a central player in that condition’s biology.3PubMed Central. The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication The connection was first established when researchers found a specific mutation in SNCA in an Italian family and three Greek families who all had inherited Parkinson’s in an autosomal dominant pattern, meaning a single copy of the mutant gene was enough to cause disease.4Semanticscholar. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease At least five different point mutations in SNCA have now been linked to dominantly inherited forms of Parkinson’s.3PubMed Central. The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication
It is worth noting that these inherited SNCA mutations account for only a small fraction of all Parkinson’s cases. Most people who develop the disease have no identifiable single-gene cause. Still, the discovery of SNCA’s role on chromosome 4 reshaped the entire field’s understanding of what goes wrong at a molecular level and opened up drug targets that researchers are still pursuing.
Achondroplasia and Bone Growth
The most common form of genetic dwarfism, achondroplasia, results from a mutation in the FGFR3 gene on chromosome 4. This gene encodes a receptor that normally acts as a brake on bone growth in cartilage. When the mutation occurs, the receptor becomes overactive, slowing the conversion of cartilage into bone during development. The result is disproportionately short limbs, a rounded head, and characteristic facial features.5PubMed Central. Achondroplasia: Development, pathogenesis, and therapy
Achondroplasia is dominantly inherited, so a single copy of the mutant gene causes the condition. Most cases, however, arise from new spontaneous mutations rather than being passed down from a parent with achondroplasia. The same FGFR3 gene is also responsible for several related skeletal conditions of varying severity. Mouse models carrying the exact human mutation reproduce the features seen in patients, including growth restriction, shortened limbs, and progressive curvature of the spine.6Scientific Reports. Knock-in human FGFR3 achondroplasia mutation as a mouse model for human skeletal dysplasia In recent years, a drug specifically designed to counteract FGFR3 overactivity received regulatory approval, making achondroplasia one of the first skeletal dysplasias with a targeted pharmaceutical treatment.
Facioscapulohumeral Muscular Dystrophy
Facioscapulohumeral muscular dystrophy, commonly called FSHD, is one of the most common forms of muscular dystrophy and has a genetic origin unlike almost any other disease. Rather than a straightforward mutation in a protein-coding gene, FSHD is caused by the loss of repeating DNA segments near the tip of chromosome 4’s long arm. These segments, called D4Z4 repeats, normally keep a gene called DUX4 switched off in most of the body’s tissues. When too many repeats are deleted, the silencing breaks down and DUX4 protein gets produced in muscle cells where it does not belong, triggering progressive muscle weakness.7PubMed Central. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence
The disease typically affects muscles in the face, shoulders, and upper arms first, though it can spread. What makes FSHD genetically unusual is that the repeat contraction alone is not sufficient. A person also needs a specific genetic variant on the same chromosome 4 copy that stabilizes the DUX4 messenger RNA, allowing the protein to accumulate. Mutations in a gene called SMCHD1, which normally helps keep D4Z4 repeats silent, can act as a disease modifier and push borderline cases into symptomatic territory.8iScience. Engineered FSHD mutations results in D4Z4 heterochromatin disruption and feedforward DUX4 network activation This layered mechanism, requiring both a structural change and a permissive genetic background, made FSHD one of the hardest muscular dystrophies to pin down genetically.
Wolf-Hirschhorn Syndrome
When a chunk of the short arm of chromosome 4 is deleted entirely, the result can be Wolf-Hirschhorn syndrome, a rare congenital condition that affects multiple organ systems. The hallmark features include a distinctive facial appearance sometimes described as resembling a Greek warrior helmet profile, growth delays, intellectual disability, and seizures.9PubMed Central. Features of the Wolf-Hirschhorn Syndrome (WHS) from Infant to Young Teenager The severity varies depending on how much genetic material is missing; larger deletions tend to produce more profound effects.
No curative treatment exists for Wolf-Hirschhorn syndrome.10PubMed Central. Generation of human induced pluripotent stem cell lines derived from Wolf-Hirschhorn syndrome patients with chromosomal 4p deletion Management focuses on controlling seizures, supporting feeding and growth, and addressing individual developmental needs. Researchers have studied whether olfactory receptor gene clusters on 4p might make the region structurally fragile and prone to breaking, but an analysis of 73 chromosome 4 rearrangements found that these gene clusters were involved in only about 11% of cases, suggesting they are not the primary driver of the deletions.11PubMed. Wolf-Hirschhorn syndrome-associated chromosome changes are not mediated by olfactory receptor gene clusters nor by inversion polymorphism on 4p16
Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease is one of the most common life-threatening single-gene disorders, affecting roughly 1 in 400 to 1 in 1,000 live births. Two genes are responsible: PKD1 on chromosome 16 accounts for about 85% of cases, while PKD2, located on chromosome 4, accounts for the remaining 15% or so. People with PKD2 mutations generally have a milder disease course than those with PKD1 mutations, reaching end-stage kidney failure at a later age.12PubMed Central. Autosomal dominant polycystic kidney disease In both forms, fluid-filled cysts gradually enlarge within the kidneys and crowd out healthy tissue. Although PKD2 disease is considered milder, “milder” is relative; many affected individuals still require dialysis or a kidney transplant eventually.
Blood Clotting and Fibrinogen
Three genes that encode the building blocks of fibrinogen, the protein your blood uses to form clots, all sit on chromosome 4. These genes are called FGA, FGB, and FGG, and together they produce the three chains (alpha, beta, and gamma) that assemble into the finished fibrinogen molecule. Mutations in any of these genes can lead to clotting disorders. In congenital afibrinogenemia, where fibrinogen is completely absent from the blood, the majority of causative mutations fall in FGA, though FGG mutations are also documented.13PubMed. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia Milder conditions like hypofibrinogenemia, where fibrinogen levels are low but not absent, can involve mutations spread across all three genes.14PubMed. Congenital hypofibrinogenemia with bleeding risk: mutations in the FGA, FGB, and FGG genes Because fibrinogen is essential for wound healing, people with these conditions face increased bleeding risk that can range from mild bruising to life-threatening hemorrhage.
Alcohol Metabolism
A cluster of genes on chromosome 4 encodes several of the alcohol dehydrogenase (ADH) enzymes your body uses to break down ethanol. At least seven different ADH genes have been identified, and four of the most clinically relevant ones, ADH1A, ADH1B, ADH1C, and ADH4, are packed into a roughly 100-kilobase stretch on this chromosome.15Scientific Reports. Genetic variants associated with alcohol dependence co-ordinate regulation of ADH genes in gastrointestinal and adipose tissues Variants in these genes influence how quickly you convert alcohol into acetaldehyde, a toxic intermediate. People who carry fast-acting versions of ADH1B or ADH1C, variants commonly found in East Asian populations, build up acetaldehyde more rapidly, producing the flushing and nausea that discourage heavy drinking. This protective effect translates into a measurably lower risk of alcohol dependence.16PubMed Central. Genes encoding enzymes involved in ethanol metabolism
Research in a Native American community found that variants in ADH4’s promoter region, as well as in ADH1B, were associated with reduced risk for alcohol withdrawal symptoms, suggesting these genes influence not just how quickly you metabolize a drink but also how your body responds to chronic exposure.17PubMed Central. Association of alcohol dehydrogenase genes with alcohol-related phenotypes in a Native American community sample The tight clustering of these genes on chromosome 4 means they tend to be inherited together, so the combination of ADH variants you carry forms a sort of metabolic profile that shapes your individual response to alcohol.
Cancer-Related Receptor Genes
Three genes encoding receptor tyrosine kinases, the proteins that sit on a cell’s surface and relay growth signals, are clustered together at chromosome 4q12. These genes are called PDGFRA, KIT, and KDR. They span about 2 million base pairs and encode receptors for well-known growth factors.18PubMed. A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12 When extra copies of this chromosomal region are produced, a phenomenon called amplification, the resulting overabundance of growth-signal receptors can push cells toward uncontrolled division. A population-level study of 390 glioblastomas found PDGFRA amplified in about 8.5% of tumors, KIT in about 4.4%, and KDR in roughly 3.3%.19PubMed. Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study
These amplifications are not unique to brain tumors. The same cluster is amplified across multiple cancer types, making it a potential drug target in the way that HER2 amplification already is in breast cancer.20PubMed Central. The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA Drugs that block KIT, such as imatinib, are already used in certain gastrointestinal and blood cancers. The physical proximity of all three genes on chromosome 4 means they are often amplified together, which complicates treatment because blocking just one receptor may not be enough when the others are also overactive.
Chromosome 4 in Leukemia
Beyond gene amplification, chromosome 4 is involved in a recurrent structural rearrangement seen in acute leukemias. In the translocation known as t(4;11), segments of chromosomes 4 and 11 swap places, fusing a gene on chromosome 4 called AF4 with a gene on chromosome 11 called MLL (now also known as KMT2A). This fusion produces an abnormal protein that drives white blood cell proliferation. The translocation is found in roughly 10% of acute lymphoblastic leukemia patients and is especially common in very young children.21Proceedings of the National Academy of Sciences. The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase Research has shown that the breakpoints on both chromosomes cluster in small regions and contain sequences resembling signals normally used for immune gene rearrangement, suggesting the cell’s own immune-gene editing machinery accidentally triggers the swap.21Proceedings of the National Academy of Sciences. The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase Unusual variants of this rearrangement exist too, including cases where chromosome 11 material gets inserted into chromosome 4 rather than swapped reciprocally.22PubMed. Insertion of chromosome 11 in chromosome 4 resulting in a 5’MLL-3’AF4 fusion gene in a case of adult acute lymphoblastic leukemia
Immune Signaling and Chemokines
Your immune system relies on signaling molecules called chemokines to direct white blood cells toward sites of infection or injury. A large cluster of CXC chemokine genes sits on chromosome 4, including the gene for interleukin-8 (IL-8), several GRO family members, and other molecules involved in inflammation. Physical mapping placed at least six of these genes within a single 335-kilobase fragment on chromosome 4, and additional related genes lie nearby.23PubMed. Physical mapping of the CXC chemokine locus on human chromosome 4 The tight clustering of these genes appears to reflect their evolutionary origin through ancient gene duplication events. From a practical standpoint, this chemokine locus is relevant to conditions involving excessive or misdirected inflammation, and variants in these genes have been studied in the context of autoimmune diseases, chronic inflammatory conditions, and tumor immunology.
A Potential Link to Longevity
Among the more intriguing findings tied to chromosome 4 is a possible connection to exceptional lifespan. A genome-wide scan of 137 sibling groups who had all lived past very old age identified significant linkage to a spot on chromosome 4, suggesting that a gene or genes in that region substantially influences the ability to reach extreme old age.24PubMed. A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4 Later genome-wide association studies reinforced this, identifying rare variants on chromosome 4 associated with extreme survival and with reduced risk for cardiovascular disease and Alzheimer’s disease.25PubMed Central. Four Genome-Wide Association Studies Identify New Extreme Longevity Variants The specific gene responsible has not been conclusively identified, and longevity is influenced by many genes interacting with lifestyle and environment. But the signal on chromosome 4 has held up across multiple studies, which makes it one of the more credible genetic longevity leads.
Albumin, Dental Proteins, and Other Genes
Not every gene on chromosome 4 ties to a dramatic disease story, but some play surprisingly essential everyday roles. The gene for human serum albumin, the most abundant protein in your blood, sits near the centromere of chromosome 4. Albumin acts as a molecular taxi, carrying hormones, fatty acids, and drugs through the bloodstream, and it helps maintain fluid balance between blood vessels and surrounding tissues. Over 70 genetic variants of albumin have been catalogued, but even in people carrying two copies of an unusual variant, the condition is benign and does not cause disease.26PubMed Central. Variations in the Human Serum Albumin Gene: Molecular and Functional Aspects
Chromosome 4 also harbors the DSPP gene, which encodes proteins critical for the formation of dentin, the hard tissue beneath tooth enamel. Mutations in DSPP cause dentinogenesis imperfecta, an inherited condition that makes teeth translucent, discolored, and prone to fracture. Around 50 different disease-causing variants in this gene have been described.27PubMed Central. Isolated dentinogenesis imperfecta: Novel DSPP variants and insights on genetic counselling The condition can appear on its own or alongside other connective tissue disorders, which makes genetic testing useful for distinguishing isolated dental problems from broader skeletal syndromes.
Evolutionary Stability and Hidden Rearrangements
From an evolutionary perspective, chromosome 4 is considered relatively stable. Comparative studies across mammals have found that the core block of genes on this chromosome has been maintained as a unit over tens of millions of years of evolution, even as other chromosomes have been extensively shuffled. In its ancestral form in placental mammals, the chromosome 4 gene block was linked to genes that now sit on chromosome 8p in humans, a partnership that was eventually split apart in the primate lineage.28Caryologia. Reconstructing the Phylogeny of the Human Chromosome 4 Synteny using Comparative Karyology and Genomic Data Analysis In other mammalian groups, the same gene content has been redistributed into different chromosomal arrangements, but the genes themselves remain recognizable. This conservation hints that the way chromosome 4’s genes are organized may matter for their regulation, not just their individual functions, and that disrupting that organization can have biological consequences.